Jaypee Brothers
In Current Chapter
In All Chapters
X
Clear
X
GO
Normal
Sepia
Dark
Default Style
Font Style 1
Font Style 2
Font Style 3
Less
Normal
More
Endocrinology in Obstetrics & Gynecology
Suvarna S Khadilkar
PART 1: FRONTIERS IN ENDOCRINOLOGY
1:
Hypothalamus
Structural Anatomy2
Output3-5
Neural Projections
Neuroendocrine Function
Hypothalamic-Adenohypophyseal (Anterior Pituitary) Axis
Hypothalamic-Neurohypophyseal (Posterior Pituitary) Axis
Clinical Relevance
Hypothalamic-adenohypophyseal (Anterior Pituitary) Axis
Hypothalamic Dysfunction
Summary
2:
Pituitary Gland
Anatomy and Physiology of the Pituitary Gland1-3
Anterior Lobe
Posterior Lobe
Intermediate Lobe
Functions
Histology1
Pituitary Disorders
3:
Pineal Gland
Introduction
Anatomical Relations of Pineal Gland
Neural Connections of Pineal Gland (Figure 2)
Histology
Type of Cell and Hormones
Biosynthesis of Melatonin (Fig. 3)
Physiology
Function of Melatonin
Applied Physiology
Pathology
4:
Ovaries
Anatomical Considerations
Histology
Corpus Luteum
Physiology
Functions of Hormones Produced in the Ovary
Pathological Involvement of the Ovary
Conclusion
5:
Testis
Introduction
Anatomy and Physiology of the Male Reproductive System (Fig. 1)
Hypothalamus–pituitary–gonadal Axis (Fig. 2)
Testis
Spermatogenesis—Stages
Epididymis
Vas Deferens
Ejaculate
6:
Thyroid Gland
Applied Anatomy and Anatomical Relations1
Histology
Physiology2 (Fig. 3)
Thyroid Function Tests
7:
Parathyroid Gland
Anatomy
Histology
Physiology
Synthesis and Metabolism of PTH
Actions of PTH
Regulation of Secretion
Pathology
Hypoparathyroidism
Hyperparathyroidism
Summary
8:
Adrenals and the Kidneys
Morphology: The Adrenal Cortex and Adrenal Medulla
Adrenal Histology and Physiology
Action and Function of the Adrenal Medulla Hormones1,2
Effect of Epinephrine and Norepinephrine
Effect of Dopamine
Action and Function of Adrenal Cortex Hormones1,2
Pathological Involvement, Hypersecretion and Effects of Glucocorticoids on Body1
Pathological Involvement, Hypersecretion and Effects of Mineralocorticoids on Body1,2
Hyposecretion of Adrenal Hormones
Kidneys
Anatomy of Kidneys
9:
Pancreas
Anatomy of Pancreas
Histomorphology of Islets
Endocrine Physiology
Insulin
Pathophysiology of Insulin Secretion
Diabetes
Insulin Excess
Insulin Preparations
Glucagon
Pathophysiology of Glucagon Secretion
Somatostatin
Pathophysiology of Somatostatin Secretion
Pancreatic Polypeptide
Pathophysiology of PP Secretion
10:
Human Skin and Adipose Tissue as Endocrine Units and Exercise Physiology
Introduction
Distribution of Adipose Tissue
Differences between White and Brown Adipose Tissues (Fig. 1)
Functions of Adipose Tissue
Metabolic, Endocrine and Paracrine Functions
Leptin
Major Influences on Leptin Expression in Human Adipose Tissue
Functions of Leptin
Leptin and Obesity
Pathophysiology
Leptin Summary
Adiponectin
Receptors
Functions of Adiponectin
Mechanism of Action of Adiponectin
Hypoadiponectinemia
Treatment with Adiponectin
Interleukin-6
Pathophysiology
Tumor Necrosis Factor (TNF) Alpha
Mechanism of TNFs Metabolic Effects
Functions of TNF Alpha
Plasminogen Activator Inhibitor-1
Functions
Macrophage and Monocyte Chemoattractant Protein (MCP)
Functions of MCP
Adipsin and Acylation Stimulating Protein (ASP)
Functions of ASP
Resistin
Functions of Resistin
Proteins of Renin Angiotensin System (RAS)
Functions of RAS
Enzymes Involved in Metabolism of Sex Steroids
Enzymes Involved in the Metabolism of Glucocorticoids
Pilosebaceous Unit
Hormone Receptors Identified in Skin
Hormone Activity on Skin
Hormone Production in the Skin
Sex Steroids
IGF-binding Protein-3 mRNA
Vitamin D
Metabolism of Hormones in the Skin
Exercise Physiology40
Hormonal Control of Substrate Mobilization during Exercise
Plasma Glucose Maintained Through Four Processes
Controlled by Hormones
Hormone-Substrate Interaction
Hormones: Regulation and Action
Conclusion
11:
Placenta and Hormonal Changes in Normal Pregnancy
Anatomy and Development of Placenta1,2
Anatomy at Term
Physiology of Placenta
Uteroplacental Circulation
Functions of Placenta
Endocrinological Function (Table 5)3-5
hCG
Role of CRH in Labor
Other functions of Placenta
Conclusion
12:
Physiology of Lactation
Introduction
Anatomy
Physiological Basis
Mammogenesis
Early Pregnancy
Mid-pregnancy
Later Pregnancy
Labor and Lactation
Lactogenesis
Secretory Initiation
Secretory Activation
Galactokinesis
Galactopoiesis
Milk Composition
Milk Production
Synthesis and Secretion of Milk Components
Exocytosis
Reverse Pinocytosis
Transcytosis
Apical Transport
Paracellular Movement
Regulation of Milk Production
Breast Emptying
Prolactin
Feedback Inhibition
Summary
PART 2: ENDOCRINOLOGY IN CLINICAL PRACTICE
13:
Normal and Abnormal Puberty
Normal Puberty
Definition
Determinants of Age at Onset of Puberty and Global Trends
The Age Limits for Normal Pubertal Development
Changes in the Secondary Sexual Characteristics in Puberty
Physiology of Onset of Puberty
Abnormal Puberty
Disorders of Puberty
Delayed Puberty
Constitutional Delay in Growth and Puberty (CDGP)
Idiopathic Hypogonadotropic Hypogonadism (IHH)
Genetic Causes of Hypogonadotropic Hypogonadism
Kallmann's Syndrome
Normosmic Hypogonadotropic Hypogonadism (nIHH)
CNS Disorders and Miscellaneous Causes
Hypergonadotropic Hypogonadism
Gonadal Dysgenesis
Steroidogenesis Defects
Complete Androgen Insensitivity Syndrome
Mayer-Rokitansky-Küster-Hauser Syndrome
Approach to the Diagnosis of a Patient with Delayed Puberty
Physical Examination
Investigations
Treatment
Reversible Causes
Treatment of Permanent Hypogonadism
Hypogonadotropic Hypogonadism
Precocious Puberty
Definition
Classification
Clinical Presentation
Central Precocious Puberty (CPP)
Hamartomas of the Tuber Cinereum
Peripheral Precocious Puberty (PPP) or Gonadotropin Independent Precocious Puberty
Benign Variants
Approach to Diagnosis of Precocious Puberty
History
Examination
Treatment
PPP
CPP
Take Home Message
14:
Disorders of Sex Development
Introduction
Revised Nomenclature
Clinical Features
Investigations
Imaging
Diagnosis
Gender Assignment in Newborn
Management
Surgical Management
Surgical Procedures
Gonadectomy
Hormonal Replacement Therapy
Psychosocial Management
Research and Future Directions in Management
Conclusion
Take Home Message
15:
Abnormalities of Growth and Pubertal Development in Adolescence
Physical Changes in Girls During Puberty
Abnormalities of Growth and Pubertal Development in Adolescence
General Approach to an Adolescent Girl with Pubertal Problems
Short Stature
Evaluation of a Short Adolescent
Tall Stature
Obesity
Evaluation of an Obese Adolescent
Hyperandrogenism and PCOS
Polycystic Ovary Syndrome
Precocious Puberty
Evaluation of Girls with Early Puberty
Delayed Puberty
Evaluation of Girl with Delayed Puberty
Primary Amenorrhea
Factors that Help in Diagnosis11
Evaluation of Girl with Amenorrhea
Take Home Message
16:
Disorders of Adrenal Gland
Introduction
Disorders of Adrenals Cortex
Hyperfunction of Adrenals
Management
Surgery for Adrenal Adenoma
Bilateral Adrenalectomy
Aldosteronism
Hypofunction of Adrenal Cortex
Primary Adrenocortical deficiency (Addison's Disease)
Treatment
Secondary Adenocortical insufficiency
Acute Adrenocortical Insufficiency
Treatment of Adrenal Crisis
Hypoaldosteronism
Congenital Adrenal Hyperplasia (Fig. 4)
21-Hydoxylase (CYP21A2, P450c21) Deficiency
Diagnosis
Treatment of Congenital Adrenal Hyperplasia
DHEA and Adrenal Imbalance
DHEA from Adrenals and Ovary
Function of DHEA and DHEAS
Tumors of Adrenal Medulla6
Pheochromocytoma
Summary
HVA VMA Metanephrine
Take Home Message
17:
Hirsutism
Introduction
Types of Disorders and Causes
Assessment of Hirsutism
Diagnosis and Differential Diagnosis
Treatment
Cosmetic Approach
Medical Management
Medical Therapy for Hirsutism may be Directed at Several Levels
Take Home Message
18:
Sex Reassignment Therapy
Sex Reassignment Therapy for Transition from Female to Male
Hormone Regimen for Female to Male2
Expected Effects of Therapy
Transdermal Testosterone
Health Risks and Side Effects of Testosterone
Side Effects of Testosterone3
Sex Reassignment Therapy for Transition from Male to Female (MTF)
Principles of Hormone Therapy4
Effects of Estrogens
Side Effects of Estrogens3
Health Risk of Estrogen Therapy3
Spironolactone
Other Antiandrogens
Progesterone
Effects of HRT
Partially Reversible Changes
Reversible Changes
Legal Status
Hormonal Management of a Child Born with Ambiguous Genitalia
Take Home Message
19:
Amenorrhea: Clinical Evaluation and Treatment
Introduction
Definitions of Amenorrhea
Causes of Amenorrhea
Physiological
Pathological
Clinical Features
Evaluation in Primary Amenorrhea
Specific Conditions Causing Primary Amenorrhea and Management in Brief
Compartment I Defects
Hypergonadotropic Hypogonadism (Compartment Defects)
Secondary Ovarian Failure-due to Hypothalamic Pituitary Dysfunction (Hypogonadotropic Hypogonadism)
Other Systemic Illnesses
Secondary Amenorrhea
Etiology of Secondary Amenorrhea
Evaluation of Secondary Amenorrhea
Disorders of Compartment I
Disorders of Compartment II
Polycystic Ovarian Syndrome
Premature Ovarian Failure
Primary Ovarian Failure (Hypergonadotropic Hypogonadism)
Masculinizing Ovarian Tumor
Pituitary or Compartment III Factors
Pituitary Adenoma/Prolactinoma
Sheehan Syndrome
Compartment IV Defects
Eating Disorders
Management of Eating Disorders
Take Home Message
20:
Prolactin Disorders
Introduction
Epidemiology
Causes of Hyperprolactinemia
Drug-induced Hyperprolactinemia
Idiopathic Hyperprolactinemia
Macroprolactinemia
Prolactinoma
Pathogenesis of Prolactinoma
Clinical Features
Diagnosis
Management
Medical Treatment of Prolactinoma
Surgical Treatment of Prolactinomas
Radiotherapy
Follow Up
Pregnancy and Prolactinoma
Malignant Prolactinoma
Take Home Message
21:
Miscellaneous Pituitary Diseases
The Pituitary Incidentaloma
Gonadotropin-producing Pituitary Tumors
GH-secreting Pituitary Adenoma (Acromegaly)
ACTH-secreting Tumors (Cushing's Disease)
Thyrotropin (TSH)-secreting Tumors
Sheehan's Syndrome
Lymphocytic Hypophysitis
Vasopressin
Reset Osmostat during Pregnancy
Diabetes Insipidus
The Syndrome of Inappropriate Antidiuretic Hormone Secretion
Oxytocin
Empty Sella Syndrome
Causes of Pituitary Failure
Trauma
Take Home Message
22:
Heavy Menstrual Bleeding
Introduction
Causes of HMB
Type of Disorder
Clinical Features
Management
Puberty Menorrhagia
Estrogen:
Progesterone - Other Routes – MIRENA
Conclusion
Take Home Message
23:
Polycystic OvarianSyndrome
Diagnosis
The Insulin Hypothesis
Clinical Evaluation of PCOS
Menstrual Abnormalities
Hyperandrogenism
Infertility
Obesity and Metabolic Syndrome
Sleep Apnea
Acanthosis Nigricans
Blood Pressure
Investigations
Tests to Clinch Diagnosis of PCOS
Recommended Investigations after Diagnosis
Other Tests to Consider
Management of PCOS
Other Drugs Used in the Management of PCOS
Raloxifene
Pioglitazone
Atorvastatin and Simvastatin7,8
Inositol
Multivitamins
Vitamin D3
N-Acetyle Cysteine
Arginine
Alpha Lipoic Acid
Ovulation Induction in Infertile Patients
Laparoscopic Ovarian Drilling
PCOS in the Adolescent
Conclusion
Take Home Message
24:
Ovulation InductionProtocols for Anovulation, PCOS, IUI and ART Cycles
Introduction
Clinical Features
Investigations
Assessment of Ovulation (Fig. 1)
Serial Basal Body Temperature
Serum Progesterone
Urinary Luteinizing Hormone
Endometrial Biopsy
Transvaginal Ultrasonography
To Determine the Cause of Anovulation
Endocrine Evaluation on Day 2/3
Prolactin and TSH, Free T4, TPO
Androgen Profile
GTT
USG
Baseline Scan
Differential Diagnosis
Ovulation Induction
Indications for Ovulation Induction
Drugs used for Ovulation Induction
Adjuvant Drugs to Prevent Premature LH Surge
Adjuvant Drugs Other than GnRh Analogs for High LH Levels in Follicular Phase
Level of Action of Ovulation Induction Drugs
Ovarian Reserve
Goal of Ovarian Stimulation (Fig. 6)
When to Start OI Drugs?
Clomiphene Citrate
Clomiphene and Glucocorticoids
Insulin Sensitizing Agents
Clomiphene and hCG
Contraindication
Risks and Complications with Clomiphene Treatment
Multiple Gestation
Congenital Anomalies
Ovarian Hyperstimulation Syndrome
Ovarian Cancer
Tamoxifen Citrate
Aromatase Inhibitors—Letrozole and Anastrozole70-72
Mechanism of Action
Advantages
Side Effects of Letrozole
Gonadotropins for Ovulation induction
Indications
Gonadotropin Preparations
The advantage of recombinant FSH is that it has:
Initial dose of GTS depends on:
Initial dose change after 4-5 days depending on E2 levels
Initial dose change after 4-5 days depending on USG finding
OI Protocols using Gonadotropins
LH on Day 2
LH on Day 5
CC/Tamoxifen + GT Protocol (Fig. 8)
Disadvantage
Kato Protocol73
hMG/FSH/Recombinant FSH
Conventional Step-up Protocol (Fig. 10)
Low Dose Protocol (Fig. 11)
Chronic Low Dose Protocol (Fig. 12)
Step Down Protocol (Fig. 13)
Sequential Protocol (Fig. 14)
Simpler Alternatives for Ovarian Stimulation
Natural Cycle
Modified Natural Cycle IVF
Mild Stimulation or Soft Protocols
Use of Long Acting FSH - Corifollitropin Alfa (Fig. 17)
Follitropin Alfa and Lutropin Alfa (2:1 Ratio) (Pergoveris)(r-hFSH 150IU and r-hLH 75IU)75,76
Contraindications of GT Therapy
Disadvantages of COH
Induction of Follicular Maturation and Ovulation
Timing of Follicular Maturation
Side Effects
Adjuvants Drugs to Gonadotropins
GnRH Analogs
GnRh Agonist
Mechanism of Action
Route of Administration
Protocols
Advantages of GnRh Agonist
Disadvantages of GnRHa
Side Effects
GnRH-antagonists
Mechanism of Action
Protocols
GnRH Antagonist – Early Administration (Fig. 24)
Down Regulation with Ovarian Steroids
OC
Norethisterone
Other Adjuvant Drugs
Treatment of Hyperprolactinemia
Prolactin Reducing Medications
Polycystic Ovary Syndrome
Why is PCOS Different?
Abnormal response of polycystic ovary to COS is due to:
Ovulation Induction in PCOS (Fig. 26)
Laparoscopic Ovarian Diathermy
Insulin Sensitizers
Metformin
Individualized COS
Cancellation of Ovarian Stimulation Cycles
Discussion
Future Directions
Oral LMW FSH and LH Agonists
Conclusion
Take Home Message
25:
Luteal Phase Support
Introduction
Luteal Phase in a Natural Cycle
Luteinizing Hormone (LH)
Progesterone
Luteal Phase Defect in a Natural Cycle
Luteal Phase Support and Pregnancy
Luteal Phase in Assisted Reproductive Technologies (ART)
Luteal Phase Support during ART
Luteal Phase Support Agents
Progesterone Supplementation
Types of Progesterone
Natural Progesterone: Routes of Administration
Oral Progesterone
Intramuscular Progesterone
Vaginal Progesterone
Progesterone Supplementation Duration
hCG and Luteal Support
Adjunct Therapy
LPS in Various Protocols
Antagonist Cycles
LPS after Ovulation Induction and Intrauterine Insemination
LPS: Cochrane Review
Michelle van der Linden (2011)15
Conclusion
Take Home Message
26:
Thyroid and Infertility
Introduction
Estrogens and Thyroid Hormones
Thyroid Disorders
Hypothyroidism and Infertility
Subclinical Hypothyroidism and Infertility
Autoimmune Thyroid Disease and Infertility
AITD and Pregnancy Outcome After Art
Recent Recommendations of American Association of Clinical Endocrinologists (AACE) and American Thyroid Associatio (ATA)16
Hyperthyroidism and Infertility
Thyroid Function after Controlled Ovarian Hytperstimulation (COH)
Take Home Message
27:
Endocrinology in Clinical Practice: Male Infertility
Hormonal Control of Spermatogenesis
History
Physical Examination
General Examination
Genital Examination
Laboratory Evaluation
Semen Analyis (Table 1)
Microscopic Features of Sperm (Fig. 1)
Other Tests
Endocrine
Genetic Testing
Imaging
Biopsy
Causes of Male Infertility (Table 2)
Sexual Dysfunction
Idiopathic Hypogonadotropic Hypogonadism (IHH)
Endocrine Therapy Regime in Hypogonadotropic Hypogonadism
Prader Willi Syndrome
Laurence-Moon-Biedl Syndrome
Pituitary Dysfunction
Prolactinoma
Isolated LH Deficiency
Isolated FSH Deficiency
Cushing Disease
Peripheral Causes for HPG Axis Disruption
Treatment
Take Home Message
28:
Hormonal Management of Endometriosis
Introduction
Management
Medical Management of Endometriosis
Hormonal Treatment
Oral Contraceptive Pill
Progestins
Selective Progesterone Receptor Modulators (SPRM)
Mifepristone (Progesterone Antagonist)
Levonorgestrel-releasing Intrauterine System
Androgens
Gonadotropin-releasing Hormone Agonists (GnRH)
Gonadotropin-releasing Hormone Antagonists
Aromatase Inhibitors
Prolactin Secretion Inhibitors
Conclusion
Take Home Message
29:
Premature Ovarian Failure
Anatomy and Embryology
Histology
Physiology
Endocrine Regulation of Folliculogenesis
Normal Range of Blood Levels5
Pathological Involvement
Hyposecretion and Effects on Body
Hypersecretion and Effects on Body
Premature Ovarian Failure
Introduction
Incidence
Presentation
Causes of POF
Genetic Causes
Inheritance of POF
Autoimmune Causes
Environmental Causes
Idiopathic Causes
Clinical Features
Investigations
Cycle History
Ultrasonography
Hormonal Evaluation
Differential Diagnosis
Ovarian Histology
Screening for Autoimmunity
Genetic Analysis
Risk Factors
Management of POF
Hormone Replacement Therapy
GnRH Therapy
Chemotherapy-induced Ovarian Damage
Inactive FSH
Idiopathic POF
Fertility Treatment
Conclusion
Take Home Message
30:
Ovarian Transplant: An Overview
Introduction
Historical Aspects
How do ovaries respond to transplantation?
Indications
Ovarian Dysgenesis
Premature Ovarian Failure
Premature Ovarian Failure Following Cancer Therapy
Donor Identification/Ovarian Tissue Procurement
Surgical Techniques
Vascular Ovarian Transplantation
Vascular Orthotopic Ovarian Transplant
Avascular Ovarian Tissue Grafting or Ovarian Implants
Take Home Message
31:
Combined Hormonal Contraceptives
Introduction
History of Hormonal Contraceptives
Combined Oral Contraceptive Pills (Table 1)
Mechanism of action
Cyclic Combined Pills
Extended/Tailored Regimes
Starting a COC Regimen
Advantages of Low-dose COCs
Disadvantages of Low-dose OCs
Combined Vaginal Rings
NuvaRing8
Design, Composition and Use
Regime
Insertion of NuvaRing
Mechanism of Action
Reversibility
Adverse Effect
Another Ring
Transdermal Contraception
Types
Transdermal Patch
Description
Sites of Application
Advantages
Disadvantages
Combined Injectable Contraceptives
Conclusion
Take Home Message
32:
Progesterone-only Contraception: Oral, Injectable, Implants, Intrauterine Systems
Introduction
First Generation
Second Generation
Third Generation
Newest Progestins
Progestogen-only Contraceptive Pill (POP) (Mini Pills)
Mechanism of Action
Effectiveness
Advantages of POPs
Disadvantages of POPs
Evaluation and Patient Selection
Counseling
Warning Signs
Conclusion
Introduction
Mechanism of Action
Contraceptive Efficacy
Advantages of Progestin Injectables
Side Effects of Progestin Injectables
Contraindications
Evaluation
Noncontraceptive Benefits
Timing of Initiation of Use
Options Available
Timing of Repeat Injections
Warning Symptoms
Counseling Tips
Conclusion
Introduction
Types of Implant
Benefits of Implantable Contraceptives
Mode of Action
Duration of Use
Effectiveness
Indications
Timing of Insertion
Switching from Another Method of Contraception
Insertion and Removal
Follow-up
Signs and Symptoms Requiring Medical Attention
Advantages
Disadvantages
Counseling
Conclusion
Introduction
Antifertility Action of Progesterone Releasing IUDs26
Mechanism of Action
Candidates for LNG-IUS
Contraindications for LNG–IUS
Patient Counseling
Patient Evaluation
Insertion
Continuation and Follow up
Effectivenes
Side Effects
Conclusion
Take Home Message
33:
Emergency Contraception
Introduction
Indications
Contraceptive Accidents Include
Types of EC and their Mechanism of Action
High Dose Estrogens
Estrogen Progestogen Combination: Yuzpe Method
Levonorgestrel Alone
Anti-progestogen Mifepristone
Other Methods Tried
Danazol
Intrauterine Contraceptive Devices (IUD)
Mechanism of Action of Hormonal EC
Management of a Request for EC
Follow-up
Problems in Clinical Practice
Ethical, Legal and Regulatory Aspects of EC
Ethical Considerations
Availability of Emergency Contraception in Different Countries
Laws for Emergency Contraception in Various Countries
Regulatory Aspects
Take Home Message
34:
Endocrinology of Medical Abortion
Introduction
Endocrinology of Early Pregnancy
Human Chorionic Gonadotropin (HCG)
Progesterone
Estradiol
IGFBP-l
Endocrine Alteration Associated with Termination of Early Pregnancy
hCG
Progesterone
Oestradiol
IGFBP-l
Regulation of IGFBP-l
Compounds used for Medical Abortion and their Mechanisms of Action
Uterotonics
Prostaglandin Analogues
Sulprostone
Gemeprost
Misoprostol
Uterine Contractility
Antimetabolites
Antiprogesterones
Mifepristone
Clinical Course of Medical Abortion Induced with a Combination of Mifepristone and Misoprostol as Reflected by Selected Endocrine Markers
Clinical Use of Medical Abortion
Take Home Message
35:
Thyroid Disorders in Pregnancy
Introduction
Physiological Changes in Pregnancy
Iodine Requirements
Effects of hCG on Thyroid Function
Thyroid Tests in Pregnancy
Types of Disorders and Causes (Table 2)
Hyperthyroidism in Pregnancy
Etiology
Graves’ Disease
Special Situations
Hyperthyroidism in Remission Following ATD Therapy
History of Ablation Therapy for Graves’ Disease
Previous Birth of an Infant with Thyroid Dysfunction
Recurrence of Hyperthyroidism in the Postpartum Period
Subclinical Hyperthyroidism
Thyroid Storm
Hypothyroidism in Pregnancy
Subclinical Hypothyroidism
Indian Data
Hypothyroidism and Pregnancy Complications
Management
Evaluation of Therapy
Overt Hypothyroidism
Diagnosis
Single Nodule of Thyroid Gland
Recommended Approach
Post-partum Thyroid Dysfunction
Predictability
Management
Differential Diagnosis
Contraception
Take Home Message
36:
Gestational Diabetes Mellitus
Introduction
Definition
Prevalence
Diagnosis
Selective Versus Universal Screening
Gestational Age at Screening
Pathophysiology of Gestational Diabetes
Physiology in Normal Pregnancy
Physiology in Gestational Diabetes Mellitus
Risk Factors
Complications of GDM
Maternal Morbidity
Hypertension
Preterm Labor
Cesarean Section and Instrumental Deliveries
Long Term Morbidity
GDM Recurrence in Subsequent Pregnancies
Type 1 and Type 2 Diabetes
Metabolic Syndrome
Cardiovascular Disease
Fetal Morbidity
Miscarriage
Birth Defects
Chromosomal Abnormalities
Growth Restriction
Macrosomia
Long Term Effects on the Offspring
Maternal and Fetal Monitoring in GDM
Ultrasonography
Doppler Studies
Monitoring Glycemic Control
Target26
Treatment
Medical Nutrition Therapy
Diet
Exercise
Pharmacotherapy
Insulin
Newer Insulins
Oral Antidiabetic Agents
Antepartum Fetal Surveillance
Timing of Delivery
Management in Labor
Elective Cesarean Section
Postpartum
Pregestational Diabetes
GDM
Neonatal Management
Early Postpartum Care
Breastfeeding
Contraception
Diet and Exercise
OGTT
2006 WHO Recommendations for the Diagnostic Criteria for Diabetes (Table 5)
Pre-pregnancy Optimization
Take Home Message
37:
Miscellaneous Endocrinopathies during Pregnancy
Introduction
Adrenal Disorders in Pregnancy
Congenital Adrenal Hyperplasia (CAH) and Pregnancy
Management
Treatment
Management Algorithm of Patient with CAH and Pregnancy
Prenatal Diagnosis and Treatment
Side Effects of Dexamethasone Treatment
Addison's Disease
Clinical Features
Diagnosis
Treatment
Cushing Syndrome with Pregnancy
Clinical Features
Fetal
Treatment
Medical Management
Surgical Treatment
Pheochromocytoma in Pregnancy
Clinical Features
Diagnosis
Treatment
Medical Treatment
Surgical Treatment
Hyperprolactinemia in Pregnancy
Management of Microprolactinoma (<10 mm) during Pregnancy
Parathyroid Disorder in Pregnancy
Clinical Features
Diagnosis
Differential Diagnosis
Management
Hypoparathyroidism with Pregnancy
Treatment
Take Home Message
38:
Endocrinological Factors in Recurrent Pregnancy Loss
Introduction
Thyroid Disorders
Management
Diabetes Mellitus
Management
Preconception
Pregnancy
PCOS
Management
Luteal Phase Deficiency
Management
Take home message
39:
Obesity Proneness at Transitional Phases in Women's Life
Introduction
Sexual Dimorphism in Obesity, Body Fat and Fat Distribution
Sexual Dimorphism in Adipose Tissue Metabolic Function
Role of Insulin in Physiologic Transitions in Women
Childhood and Adolescent Obesity and the Pubertal Transition
Pregnancy and Obesity
Obesity and Menopause
Conclusion
Take Home Message
40:
Menopause: Physiology and Symptomatology
Introduction
Evolution of Menopause
Classification and Definitions
Staging System
Age of Menopause
Physiology of Menopause17
Ultrasound and Endocrine Markers
Antral Follicle Count (AFC)
Inhibin-B
Anti-Mullerian Hormone (AMH)
Symptomatology of Menopause (Fig. 2)
Early Symptoms of Menopause
Vasomotor Symptoms and Hot Flushes
Irregular and Abnormal Bleeding
Urogenital Problems
Sleep Disturbances, Mood, Depression
Long-term Consequences of Estrogen Deficiency
Cardiovascular Diseases
Osteoporosis5
The Skin and Hair Changes
Concentration and Memory
Ocular Changes
Treatment
Conclusion
Take Home Message
41:
Management Options in Menopause
Introduction
Menopausal Health Trends
Symptoms and Long-term Consequences
Management (Flowchart 1)
Screening
Lifestyle Measures
Exercise
Diet
Supplements
Nonhormonal Therapy
Phytoestrogens
DT56a
Dehydroepiandrosterone (DHEA)
Vasomotor Symptoms
Drug Therapy
Vaginal Atrophy
Urinary Symptoms
Osteoporosis
Bisphosphonates
Raloxifene
Calcitonin
Parathyroid Hormones
Cardiovascular Health
Hormone Therapy
Conclusion
Take Home Message
42:
Menopausal Hormone Therapy: An Update
The WHI Trial
Vasomotor Symptoms
Urogenital Atrophy
Osteoporosis
Cardiovascular Disease
MHT and Cancer
Breast Cancer
Endometrial Cancer
Alzheimer's Disease
What does current evidence say?
Drugs and Formulations in MHT
Conventional HT
Estrogen
Route of Estrogen administration
Oral
Non-oral
Progestogens
Regimens of Estrogen-progestogen Use
Contraindications
Side effects Associated with Estrogen and Progesterone
Estrogenic Side Effects
Progestogenic Side Effects
Androgens
Contraindications of Androgens
Androgenic Preparations
Place for Androgen Therapy in Clinical Practice
Profile of an Ideal Hormone Therapy
Other Hormones
Tibolone
Specific Indications for Tibolone
SERMS: Raloxifene
Effects on Tissues
Bone
Breast
Endometrial Tissue 27
Effect on Lipids
Cognitive Functions
Dosage and Administration
Side Effects
Indications
Teriparatide
Take Home Message
43:
Osteoporosis: Risk Factors, Diagnosis and Assessment of Fracture Risk
Introduction
Causes and Risk Factors
Causes
Primary Osteoporosis
Secondary Osteoporosis
Risk Factors for Osteoporosis
Screening for Osteoporosis and Assessment of Fracture Risk
Clinical Evaluation
Biochemical Investigations
Routine Laboratory Screening
Specific Bone Turnover Markers
Measurement of BMD
Radiological Methods for Measuring BMD
Measurement of Multiple Skeletal Sites
Fracture Risk
Limitations of BMD
Clinical Risk Factors
Risk Assessment Tools
Approach to Assessment of an Individual at Risk of Fracture
Conclusion
Take Home Message
44:
Prevention and Management of Osteoporosis
Prevention of Osteoporosis
Dietary Measures
Exercise
Pharmacologic Therapy
Expert Recommendations
Bisphosphonates
Zoledronic Acid
Bisphosphonates and Bone Turnover
Treatment Interval and Complications with Bisphosphonate Therapy
Selective Estrogen Receptor Modulator
Parathyroid Hormone
Calcitonin
Denosumab
Hormone Replacement Therapy
Other Agents
Physical Therapy
Occupational Therapy
Take Home Message
45:
Sarcopenia in Women
Introduction
Classification
Hormones
Clinical Features
Investigations
Differential Diagnosis
Cachexia
Therapy
Non-pharmacological
Estrogen and HRT
Tibolone
Isoflavones
Conclusion
Flow Diagram
Take Home Message
46:
Hormones and Breast Cancer
Introduction
History
Pathophysiology
Biological Effect of Estrogen on Breast Tumors
Estrogen Receptor
Principle of Hormonal Treatment
Clinical Use
Drugs: Indication, Dose, Adverse Effects and duration of use
Aromatase Inhibitors (AI): Letrozole, Anastrozole, Exemestane
Principles of Hormone Treatment in Breast Cancer
Development of Hormonal Resistance
Future
Take Home Message
47:
Hormones and Cancer
Hormones and Cancers
Endometrial Carcinoma
Risk Factors
Tamoxifen and Endometrial Carcinoma
Hormone Replacement Therapy and Endometrial Carcinoma
Oral Contraceptive Pills and Endometrial Cancer
Hormonal Treatment for Endometrial Carcinoma
Role of Hormone Replacement Therapy after Endometrial Cancer Treatment
Recommendations19
Hormones and Ovarian Carcinoma
Risk Factors for Ovarian Carcinoma
Hormone Replacement Therapy and Risk of Ovarian Carcinoma
Hormone Replacement Therapy After Ovarian Cancer Treatment
Recommendations
Hormones and Cervical Cancer
OC Pills and Cervical Cancer
The Possible Postulated Mechanism
Hormone Replacement Therapy and Risk of Breast Cancer
Conclusions
Take Home Message
48:
Hormones and Ovarian Cancer
Introduction
Hormonally Active Ovarian Tumors
Sex Cord Stromal Tumors
Granulosa Cell Tumors
Thecomas
Sertoli Leydig Cell Tumors
Sex Cord Tumors with Annular Tubules (SCTAT)
Gynandroblastoma
Steroid Cell Neoplasms/Lipid Cell Neoplasms
Other Hormonally Active Ovarian Tumors
Protective and Detrimental Effects of Hormones on Ovarian Cancer
Take Home Message
INDEX
TOC
Index
×
Chapter Notes
Save
Clear